Clinical Trials Directory

Trials / Completed

CompletedNCT01465009

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold

Double-blind, Randomized, Placebo-controlled, Single Dose, Parallel Group Study Evaluating Efficacy and Safety of 1000 mg Acetylsalicylic Acid and 1000 mg Paracetamol in Adult Patients With Sore Throat Associated With a Common Cold

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
508 (actual)
Sponsor
Bayer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the efficacy and safety of 1000 mg Aspirin (study medication) by comparing 1000 mg Paracetamol (study medication) in treating the symptoms of sore throat associated with a common cold. The study is designed to develop a treatment method against sore throat associated with a common cold which will have more advantages for patients than the methods that are currently available.

Conditions

Interventions

TypeNameDescription
DRUGAcetylsalicylic acid (Aspirin, BAYE4465)Single Administration of 2 tablets Acetylsalicylic acid (500 mg each); in addition, 2 tablets matching placebo to Paracetamol
DRUGParacetamolSingle Administration of 2 tablets Paracetamol (500 mg each); in addition, 2 tablets matching placebo to Acetylsalicylic Acid
DRUGPlaceboSingle Administration of 2 tablets matching Placebo to Acetylsalicylic Acid together with 2 tablets matching placebo to Paracetamol

Timeline

Start date
2003-11-01
Completion
2005-03-01
First posted
2011-11-04
Last updated
2014-12-11

Locations

8 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01465009. Inclusion in this directory is not an endorsement.

Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Assoc (NCT01465009) · Clinical Trials Directory